Results 101 to 110 of about 2,077 (188)

Early Effect of 0.005% Estriol Vaginal Gel on Symptoms and Signs of Vulvovaginal Atrophy. [PDF]

J Menopausal Med, 2022
Lázaro-Carrasco de la Fuente J, Cuerva González M, González Rodríguez S, Delgado Marín JL, Cuevas Castillo C, Nieto Magro C.   +5 more
europepmc   +1 more source

Genitourinary syndrome of lactation – a new name for an old problem?

Клинический разбор в общей медицине
Until recently, it was difficult to discuss such a narrow, complex problem associated with the physiological/lactation amenorrhea due to terminological defects and the lack of appropriate attention to the problem from both medical science and clinicians.
Mekan R. Orazov, Viktor E. Radzinsky, Evgeny D. Dolgov   +2 more
doaj   +1 more source

An online survey on coping methods for genitourinary syndrome of menopause, including vulvovaginal atrophy, among Japanese women and their satisfaction levels. [PDF]

BMC Womens Health, 2023
Ohta H, Hatta M, Ota K, Yoshikata R, Salvatore S.   +4 more
europepmc   +1 more source

Primavera: A new therapeutical approach to vulvo‐vaginal atrophy

, 2018
Vulvovaginal atrophy is a condition that affects women, although it is mainly associated with the onset of menopause mainly due to hormonal changes vulvovaginal laxity and mucosal atrophy can also affect women at different life stages such as after ...
Hercogova, Jana, Franca, Katlein, Di Nardo, Veronica, Wollina, Uwe, Amori, Paolo, Vitiello, Gabriella, Lotti, Torello, Daaboul, Farah, Tchernev, Georgi   +8 more
core   +1 more source

The efficacy of fractional CO2 laser treatment on postpartum vulvovaginal atrophy: A prospective observational study

Objective: To investigate the changes of vaginal health and vulvovaginal atrophy (VVA) symptoms following CO2 laser treatment in postpartum breastfeeding women.
Yeou-Lih Wang, Chun-Yuan Su, Wen-Chu Huang   +2 more
core   +1 more source

Efficacy, tolerability, and endometrial safety of ospemifene compared with current therapies for the treatment of vulvovaginal atrophy: a systematic literature review and network meta-analysis. [PDF]

Menopause, 2023
Simon JA, Ferenczy A, Black D, Castonguay A, Royer C, Marouf R, Beauchemin C.   +6 more
europepmc   +1 more source

Vulvovaginal atrophy after gynecological cancer: etiology, epidemiology, diagnostics and management (review of the literature).

Aim: Review the etiology, epidemiology, diagnostics and treatment options of vulvovaginal atrophy that occurs following oncogynecologic treatment. Objectives: 1) Describe etiology; 2) Investigate prevalence and risk factors; 3) Describe diagnostic ...
Narutytė, Ramunė,
core  

Effects of Non-Ablative Solid-State Vaginal Laser (SSVL) for the Treatment of Vulvovaginal Atrophy in Breast Cancer Survivors after Adjuvant Aromatase Inhibitor Therapy: Preliminary Results. [PDF]

J Clin Med, 2023
Lubián-López DM, Butrón-Hinojo CA, Menjón-Beltrán S, González-Mesa E, Tapiador-Albertos S, Rodríguez-Jiménez B, Fiol-Ruiz G.   +6 more
europepmc   +1 more source

Non–invasive vulvovaginal rejuvenation: A review

Background: Non–invasive vulvovaginal rejuvenation is a promising option for women who want to restore the appearance and function of the vagina. Vaginal atrophy and vulvovaginal laxity are caused by several circumstances, including ageing, menopause ...
Dhillon, Jesryn, Jusuf, Nelva Karmila
core   +1 more source

Vaginal hormone-free moisturising cream is not inferior to an estriol cream for treating symptoms of vulvovaginal atrophy: Prospective, randomised study. [PDF]

PLoS One, 2022
Garcia de Arriba S, Grüntkemeier L, Häuser M, May TW, Masur C, Stute P.   +5 more
europepmc   +1 more source